Evidence map›Paper›PMID 39537719›Full record

ArticleScientific reports2024

Characterization of variably protease-sensitive prionopathy by capillary electrophoresis.

Jennifer Myskiw, Ben A Bailey-Elkin, Kristen Avery, Marcelo A Barria, Diane L Ritchie, Mark L Cohen, Brian S Appleby, Stephanie A Booth

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jennifer MyskiwMycobacteriology, Vector-borne and Prion Diseases Division, Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB, Canada.
Ben A Bailey-ElkinMycobacteriology, Vector-borne and Prion Diseases Division, Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB, Canada.
Kristen AveryMycobacteriology, Vector-borne and Prion Diseases Division, Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB, Canada.
Marcelo A BarriaNational CJD Research and Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Diane L RitchieNational CJD Research and Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Mark L CohenNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA.
Brian S ApplebyNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA.
Stephanie A BoothMycobacteriology, Vector-borne and Prion Diseases Division, Public Health Agency of Canada, National Microbiology Laboratory, Winnipeg, MB, Canada. stephanie.booth@phac-aspc.gc.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Variably Protease Sensitive Prionopathy (VPSPr) is a rare human prion disease that, like Creutzfeldt-Jakob disease (CJD), results in the deposition of abnormally folded prion protein aggregates in the brain and is ultimately fatal. Neuropathology and clinical features of VPSPr are heterogeneous. However, the key discriminating feature is the relative sensitivity of the pathological prion protein to proteinase digestion compared to that typically seen in other human prion cases. Three major fragments of 23, 17 and 7 kDa are characteristic of the disease following digestion with proteinase K. We recently reported the utility of the highly adaptive and reproducible ProteinSimple™ capillary electrophoresis (CE) system to perform protein separation of PK digested prion protein in CJD. Consequently, we explored capillary-based electrophoresis (CE) technology as a sensitive method to detect and characterize VPSPr in a cohort of 29 cases. The unique 7 kDa fragment has high intensity, particularly in cases with the codon 129 VV genotype, but can be missed by regular Western blotting due to the small size. However, this fragment is readily detected by CE in all cases. In addition, the flexibility of CE produced highly reproducible, semi-quantitative data for determining relative proteinase K sensitivity and epitope mapping of representative cases from each codon 129 genotype (VV, MV and MM).

Indexed as

Creutzfeldt-Jakob SyndromeElectrophoresis, CapillaryAgedBrainEndopeptidase KFemaleHumansMaleMiddle AgedPrion DiseasesEndopeptidase K

Identifiers

PMID39537719
PMCPMC11561330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.